Alagille (AGS) syndrome is variably characterized by chronic cholestasis due to paucity of intrahepatic bile ducts, peripheral pulmonary artery stenosis, vertebrae segmentation anomalies, characteristic facies, posterior embryotoxon/anterior segment abnormalities, pigmentary retinopathy, and dysplastic kidneys.
Comprehensive, easy-to-understand information about this condition
Checking for content...
The Alagille Syndrome Alliance (ALGSA) is an international nonprofit started in 1993, representing the ALGS community. With 2 staff members and 9 board members spanning globally from London, India, Canada, and the US, they provide advocacy and support for people affected by Alagille syndrome.
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Neu-Laxova syndrome
MONDO:0000179
inclusion body myopathy with Paget disease of bone and frontotemporal dementia
MONDO:0000507
syndromic intellectual disability
MONDO:0000508
abdominal obesity-metabolic syndrome
MONDO:0000816
fibrogenesis imperfecta ossium
MONDO:0000849
Fanconi renotubular syndrome
MONDO:0001083